Review: taking Pepcid ac and Levaquin together


Summary

Drug interactions are reported among people who take Pepcid ac and Levaquin together. This review analyzes the effectiveness and drug interactions between Pepcid ac and Levaquin. It is created by eHealthMe based on reports of 1,149 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pepcid ac and Levaquin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pepcid Ac

Pepcid ac has active ingredients of famotidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pepcid ac 3,444 users)

Levaquin

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. (latest outcomes from Levaquin 30,922 users)

On Aug, 27, 2016

1,149 people who take Pepcid Ac, Levaquin are studied.


Number of reports submitted per year:

Pepcid ac and Levaquin drug interactions.

Drug effectiveness over time:

Pepcid Ac:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Levaquin:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Pepcid Ac:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Levaquin:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Pepcid Ac:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Levaquin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • pain
  • myocardial infarction
  • heart rate increased
  • injury
  • muscle spasms
  • renal failure
  • tendon pain
  • asthenia
  • back pain
  • mental status changes
1 - 6 months:
  • death
  • stevens-johnson syndrome
  • hypotension
  • rash
  • sinus tachycardia
  • ventricular extrasystoles
  • abdominal distension
  • acute myocardial infarction
  • allergic granulomatous angiitis
  • arthralgia
1 - 2 years:
  • nephrogenic systemic fibrosis
2 - 5 years:
  • deep vein thrombosis
  • emotional distress
  • fear
  • injury
  • pain
  • pulmonary embolism
  • anhedonia
  • anxiety
  • death
10+ years:
  • anxiety
  • deep vein thrombosis
  • emotional distress
  • general physical health deterioration
  • injury
  • pain
  • pulmonary embolism
not specified:
  • pain
  • anxiety
  • nausea
  • back pain
  • dyspnoea
  • osteonecrosis of jaw
  • diarrhoea
  • arthralgia
  • injury
  • pain in extremity

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • back pain
  • diarrhoea
  • arthralgia
  • injury
  • osteonecrosis of jaw
  • dyspnoea
  • fatigue
male:
  • pain
  • anxiety
  • nausea
  • arthralgia
  • back pain
  • chest pain
  • injury
  • pneumonia
  • osteoarthritis
  • renal failure acute

Most common drug interactions by age *:

2-9:
  • fungal test positive
  • hypokalaemia
  • transfusion reaction
  • bronchiectasis
  • culture positive
  • rash
  • respiratory tract infection fungal
  • restrictive pulmonary disease
  • stem cell transplant
  • catheter site discharge
10-19:
  • nausea
  • abdominal pain
  • abdominal pain upper
  • cholelithiasis
  • decreased appetite
  • abdominal pain lower
  • asthenia
  • bile duct stone
  • cholecystitis chronic
  • enuresis
20-29:
  • vomiting
  • pain
  • anxiety
  • pulmonary embolism
  • abdominal pain
  • injury
  • emotional distress
  • diarrhoea
  • deep vein thrombosis
  • back pain
30-39:
  • back pain
  • anxiety
  • osteoarthritis
  • pulmonary embolism
  • osteonecrosis of jaw
  • pain in extremity
  • dry mouth
  • pain
  • intervertebral disc protrusion
  • nausea
40-49:
  • nausea
  • anxiety
  • pain
  • back pain
  • chest pain
  • fatigue
  • asthenia
  • pyrexia
  • dyspnoea
  • injury
50-59:
  • osteoarthritis
  • diarrhoea
  • arthralgia
  • osteonecrosis of jaw
  • back pain
  • nausea
  • pneumonia
  • intervertebral disc protrusion
  • pain
  • decreased appetite
60+:
  • pain
  • anxiety
  • nausea
  • injury
  • diarrhoea
  • dyspnoea
  • arthralgia
  • asthenia
  • urinary tract infection
  • osteonecrosis of jaw

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pepcid ac and Levaquin?

You may be interested in these reviews

More reviews for: Pepcid ac, Levaquin

On eHealthMe, Pepcid ac (famotidine) is often used to treat gastrooesophageal reflux disease. Levaquin (levofloxacin) is often used to treat sinusitis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.